Abraham Silji's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed May 2, 2023
- Accession no.
- 0001562180-23-003795
- Filed
- May 2, 2023
- Trade date
- May 1, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.93M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Abraham SiljiCIK 0001733001 | Officer (SVP, Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | Common Stock | MOption exerciseAcquired | +8,020 | $86.24 | +$691,644.8 | 12,229.3 | Direct | |
| May 1, 2023 | Common Stock | SSaleDisposed | −7,371 | $365.55 | −$2,694,469.05 | 4,858.3 | Direct | |
| May 1, 2023 | Common Stock | SSaleDisposed | −649 | $366.14 | −$237,624.86 | 4,209.3 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2023 | Common Stock | MOption exerciseDisposed | −8,020 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.